Insights Into Myelofibrosis (MF)

Perspectives on drivers in treatment decisions in the management of myelofibrosis (MF)

Central #1 – March 20, 2023

Faculty Chair

Pankit Vachhani, MD

O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA

Midwest #1 – March 27, 2023

Faculty Chair

Pankit Vachhani, MD

O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA

Southwest #1 – April 3, 2023

Faculty Chair

Pankit Vachhani, MD

O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA

Northeast #1 – April 4, 2023

Faculty Chair

Raajit Rampal, MD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

Northwest #1 – April 10, 2023

Faculty Chair

Pankit Vachhani, MD

O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA

Southeast #1 – April 10, 2023

Faculty Chair

Nikolai Podoltsev, MD, PhD

Yale School of Medicine, New Haven, CT, USA

Midwest #2 – April 17, 2023

Faculty Chair

Rami Komrokji, MD

Moffitt Cancer Center, Tampa, FL, USA

Southwest #2 – April 27, 2023

Faculty Chair

Abdulraheem Yacoub, MD

University of Kansas Medical Center, Kansas City, KS, USA

Southeast #2 – May 1, 2023

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Northeast #2 – May 2, 2023

Faculty Chair

Raajit Rampal, MD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

Northeast #3 – May 8, 2023

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Southeast #3 – May 9, 2023

Faculty Chair

Raajit Rampal, MD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

Midwest #3 – May 10, 2023

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Northeast #4 – May 15, 2023

Faculty Chair

Rami Komrokji, MD

Moffitt Cancer Center, Tampa, FL, USA

Northwest #2 – May 16, 2023

Faculty Chair

Abdulraheem Yacoub, MD

University of Kansas Medical Center, Kansas City, KS, USA

Central #2 – May 16, 2023

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Northwest #3 – May 16, 2023

Faculty Chair

Kristin Petit, MD

C.S. Mott Children's Hospital, Ann Arbor, MI, USA

Southwest #3 – May 17, 2023

Faculty Chair

Kristin Petit, MD

C.S. Mott Children's Hospital, Ann Arbor, MI, USA

Southwest #4 – May 18, 2023

Faculty Chair

Abdulraheem Yacoub, MD

University of Kansas Medical Center, Kansas City, KS, USA

Southeast #4 – May 22, 2023

Faculty Chair

Raajit Rampal, MD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

Midwest #4 – May 25, 2023

Faculty Chair

Abdulraheem Yacoub, MD

University of Kansas Medical Center, Kansas City, KS, USA

Central #3 – May 30, 2023

Faculty Chair

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX, USA

Central #4 – July 31, 2023

Faculty Chair

Raajit Rampal, MD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

More Information

  • Virtual series
  • Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana

More Information

  • Virtual series
  • Illinois, Iowa, Minnesota, Nebraska, North Dakota, South Dakota, Wisconsin, Michigan, Indiana, Ohio

More Information

  • Virtual series
  • Southern California, Nevada, Utah, Arizona, New Mexico, Colorado

More Information

  • Virtual series
  • Connecticut, Delaware, DC, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont

More Information

  • Virtual series
  • Northern California, Oregon, Washington, Idaho, Montana, Wyoming

More Information

  • Virtual series
  • Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia

More Information

  • Virtual series
  • Illinois, Iowa, Minnesota, Nebraska, North Dakota, South Dakota, Wisconsin, Michigan, Indiana, Ohio

More Information

  • Virtual series
  • Southern California, Nevada, Utah, Arizona, New Mexico, Colorado

More Information

  • Virtual series
  • Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia

More Information

  • Virtual series
  • Connecticut, Delaware, DC, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont

More Information

  • Virtual series
  • Connecticut, Delaware, DC, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont

More Information

  • Virtual series
  • Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia

More Information

  • Virtual series
  • Illinois, Iowa, Minnesota, Nebraska, North Dakota, South Dakota, Wisconsin, Michigan, Indiana, Ohio

More Information

  • Virtual series
  • Connecticut, Delaware, DC, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont

More Information

  • Virtual series
  • Northern California, Oregon, Washington, Idaho, Montana, Wyoming

More Information

  • Virtual series
  • Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana

More Information

  • Virtual series
  • Northern California, Oregon, Washington, Idaho, Montana, Wyoming

More Information

  • Virtual series
  • Southern California, Nevada, Utah, Arizona, New Mexico, Colorado

More Information

  • Virtual series
  • Southern California, Nevada, Utah, Arizona, New Mexico, Colorado

More Information

  • Virtual series
  • Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia

More Information

  • Virtual series
  • Illinois, Iowa, Minnesota, Nebraska, North Dakota, South Dakota, Wisconsin, Michigan, Indiana, Ohio

More Information

  • Virtual series
  • Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana

More Information

  • Virtual series
  • Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana

Example Agenda

Download the meeting agenda

View Agenda

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of MF
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies will be obtained
    • Current management and emerging challenges in MF
    • Current therapy paradigms for MF
    • Unmet needs and emerging paradigms

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprises 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.